ZA200703704B - Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke - Google Patents

Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke

Info

Publication number
ZA200703704B
ZA200703704B ZA200703704A ZA200703704A ZA200703704B ZA 200703704 B ZA200703704 B ZA 200703704B ZA 200703704 A ZA200703704 A ZA 200703704A ZA 200703704 A ZA200703704 A ZA 200703704A ZA 200703704 B ZA200703704 B ZA 200703704B
Authority
ZA
South Africa
Prior art keywords
plasminogen
intravenous injection
treating cerebral
cerebral stroke
neurotoxic
Prior art date
Application number
ZA200703704A
Other languages
English (en)
Inventor
Soehngen Mariola
Soehngen Wolfang
Scheuning Wolf-Dieter
Medcalf Robert
Original Assignee
Paion Deutschalnd Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paion Deutschalnd Gmbh filed Critical Paion Deutschalnd Gmbh
Publication of ZA200703704B publication Critical patent/ZA200703704B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA200703704A 2003-05-02 2004-04-30 Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke ZA200703704B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EPPCT/EP03/04608 2003-05-02

Publications (1)

Publication Number Publication Date
ZA200703704B true ZA200703704B (en) 2008-08-27

Family

ID=33395696

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200703704A ZA200703704B (en) 2003-05-02 2004-04-30 Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
ZA200509053A ZA200509053B (en) 2003-05-02 2004-04-30 Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral storke

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200509053A ZA200509053B (en) 2003-05-02 2004-04-30 Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral storke

Country Status (14)

Country Link
JP (1) JP2012077090A (da)
CN (1) CN1849133B (da)
AU (3) AU2003227721A1 (da)
CY (1) CY1114254T1 (da)
DK (1) DK1622639T3 (da)
EA (2) EA201000501A1 (da)
ES (1) ES2401782T3 (da)
HK (1) HK1092045A1 (da)
IL (1) IL171636A (da)
MY (1) MY151447A (da)
PT (1) PT1622639E (da)
SI (1) SI1622639T1 (da)
WO (1) WO2004096267A1 (da)
ZA (2) ZA200703704B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153601A1 (de) 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
TWI445540B (zh) 2007-04-20 2014-07-21 Ajinomoto Kk 抗低體溫組成物
EP2014296A1 (en) * 2007-07-10 2009-01-14 PAION Deutschland GmbH Novel strategies for increasing the reperfusion in obstructed blood vessel
AR067345A1 (es) * 2007-07-10 2009-10-07 Paion Deutschland Gmbh Uso de trombomodulina para la preparacion de un medicamento trombolitico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK176140B1 (da) * 1988-07-20 2006-09-25 Schering Ag Patentabteilung Flagermusspyt-plasminogenaktivatorer
NL8902454A (nl) * 1989-10-03 1991-05-01 Stichting Centraal Lab Mutanten van de humane plasminogeen activator inhibitor 1 (pai-1), hun bereiding en toepassing, en recombinante polynucleotiden die voor deze mutanten coderende genetische informatie omvatten.
RU2128705C1 (ru) * 1991-09-05 1999-04-10 Шеринг Аг Протеин, ингибирующий вызываемую коллагеном агрегацию тромбоцитов млекопитающих, рекомбинантный протеин, ингибирующий вызываемую коллагеном агрегацию тромбоцитов, фрагмент днк, кодирующий рекомбинантный протеин, вектор экспрессии (варианты), штамм культивируемых животных клеток внк - продуцент рекомбинантного протеина (варианты), способ получения рекомбинантного протеина, фармацевтическая композиция
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall

Also Published As

Publication number Publication date
AU2004233601A1 (en) 2004-11-11
ZA200509053B (en) 2007-11-28
AU2004233601B2 (en) 2009-11-26
SI1622639T1 (sl) 2013-05-31
AU2010200718A1 (en) 2010-03-18
DK1622639T3 (da) 2013-04-15
JP2012077090A (ja) 2012-04-19
CN1849133B (zh) 2011-03-30
IL171636A (en) 2013-07-31
PT1622639E (pt) 2013-04-01
HK1092045A1 (en) 2007-02-02
CY1114254T1 (el) 2016-08-31
CN1849133A (zh) 2006-10-18
WO2004096267A1 (de) 2004-11-11
EA201000501A1 (ru) 2010-10-29
ES2401782T3 (es) 2013-04-24
EA200501733A1 (ru) 2006-06-30
AU2003227721A1 (en) 2004-11-23
EA013837B1 (ru) 2010-08-30
MY151447A (en) 2014-05-30

Similar Documents

Publication Publication Date Title
NO20055692D0 (no) Intravenos injeksjon av ikkeneurotoksiske plasminogenaktivatorer til behandling av cerebralt slag
EG24106A (en) Machine for injecting liquids
HK1070386A1 (en) Methods for production of recombinant urokinase
EP1859914A4 (en) METHOD FOR ADJUSTING THE CASTING CONDITIONS AND METHOD FOR CONTROLLING AN INJECTION MOLDING MACHINE
HK1091410A1 (en) Tlr7 ligands for the treatment of hepatitis c
IL173439A0 (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
IL175014A0 (en) Method of administering therapeutic injections
PL372211A1 (en) Thiazolyl urea compounds for the treatment of cancer
AU2003295537A8 (en) Methods of treating cerebral ischemia
HUP0402165A3 (en) Non-neurotoxic plasminogen activating factors for treating stroke
ZA200703704B (en) Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
AU2002350660A1 (en) Non-neurotoxic plasminogen activating factors for treating stroke
SI1697383T1 (sl) Postopek za čiščenje takrolimusa
EP1626692A4 (en) COMPOUNDS FOR TREATING FLAVIVIRUS INFECTIONS
HK1087064A1 (en) Injection-molding machine and method of controlling injection-molding machine
AU2003296705A8 (en) Method for controlling the production of injection molded parts
IL173953A0 (en) Plasminogen activators
EP1684783A4 (en) NEUROPROTECTIVE EFFECTS OF GLY-PRO-GLU AFTER INTRAVENOUS INFUSION
AU2003213596A8 (en) Intraspinal continuous infusion of midazolam hydrochloride for the treatment of pain
ZA200603153B (en) Pyridine compounds as inhibitors of dipetidyl peptidase IV
GB0522551D0 (en) Process control for gas-assisted injection molding applications
TW569918U (en) Auxiliary jig for forming mold of needle injecting type label piece
GB0125597D0 (en) Controlling injection moulding processes
GB0310915D0 (en) Needle assembly for gas-assisted injection moulding
EP1598355A4 (en) THERAPEUTIC AGENT FOR SCHIZOPHRENIA